Error: Could not add to watchlist. X
+ Watchlist

Franklin Strategic Series - Franklin Biotechnology Discovery Fund

FBTDX:US
NASDAQ GM
157.46
USD
0.62
0.40%
As of 9:29 AM EDT 9/20/2017
Fund Type
Open-End Fund
52Wk Range
117.10 - 159.28
1 Yr Return
13.51%
YTD Return
23.88%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Previous Close
156.84
52Wk Range
117.10 - 159.28
1 Yr Return
14.17%
YTD Return
23.88%
Fund Type
Open-End Fund
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
U.S.
NAV (on 09/20/2017)
157.46
Total Assets (b USD) (on 07/31/2017)
1.193
Inception Date
09/15/1997
Last Dividend (on 12/15/2016)
4.2035
Dividend Indicated Gross Yield
0.82%
Fund Managers
EVAN MCCULLOCH
Front Load Fee
0.00%
Back Load Fee
1.00%
Redemption Fee
-
12b-1 Fee
1.00%
Current Mgmt Fee
0.59%
Expense Ratio
1.70%

Top Fund Holdings

Name Position Value % of Fund
1.08 m 139.86 m 9.97
851.80 k 103.64 m 7.39
653.20 k 82.24 m 5.86
159.11 k 78.14 m 5.57
236.46 k 64.17 m 4.57
854.10 k 60.45 m 4.31
320.40 k 55.60 m 3.96
579.40 k 54.25 m 3.87
352.34 k 49.28 m 3.51
378.30 k 48.75 m 3.48
Profile
Franklin Biotechnology Discovery Fund is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund invests at least 80% of its net assets in securities of biotechnology companies and discovery research firms. The Fund invests a substantial portion of its assets in equity securities of smaller capitalization companies.
Address
Franklin Templeton Investments
One Franklin Parkway
Building 970
1st Floor
San Mateo, CA 94403
Phone
1-800-632-2350